Meagan Parrish
Lead Editor | LinkedInMeagan Parrish is the lead editor for PharmaVoice. She got her professional start as an editor at a women’s magazine in her current home of Madison, Wisconsin, before jumping into B2B industry reporting. She spent three years covering the chemicals, energy, food and healthcare sectors at numerous publications, and then became a full-time pharma journalist. During her four years as senior editor at Pharma Manufacturing, Meagan was a three-time Neal Awards finalist, and was honored to receive numerous other accolades for her industry reporting. Her highest honor was the Stephen Barr Award, a prestigious “best in show” award chosen from the 2020 pool of Gold-winning articles by the American Society of Business Publication Editors (ASBPE) for her coverage of contaminated APIs in drugs imported from overseas. Pharma Manufacturing also snagged the 2021 Magazine of the Year award from ASBPE. Meagan joined PharmaVoice in late 2021 after the publication was acquired by Industry Dive and relaunched as a daily digital. But Meagan’s most important job is being Mom to her two daughters and teaching them to cook, dance and talk in funny accents.
86 articles by Meagan Parrish
-
The PharmaVoice 100: Standout execs
Sept. 25, 2023 -
Catching up with 2022 PharmaVoice 100 honorees
Sept. 13, 2023 -
Roz Brewer announces sudden departure as CEO of Walgreens
Sept. 1, 2023 -
A startup’s psychedelic delivery tech is grabbing attention. Will pharma listen?
Sept. 1, 2023 -
Woman of the Week: Novartis’ Christy Siegel
Aug. 15, 2023 -
Pharma’s rare disease rush
Aug. 14, 2023 -
5 minutes with — Lundbeck CEO Dr. Deborah Dunsire
Aug. 11, 2023 -
Woman of the Week: AmyriAD Therapeutics’ Sharon Rogers
Aug. 9, 2023 -
Is the COVID-19 market crashing?
Aug. 3, 2023 -
A leading CRO’s chief exec on why a ‘brave new world’ of clinical research is here
July 20, 2023 -
How steep is pharma’s patent cliff?
June 14, 2023 -
Why cancer could be the ideal realm for psychedelic treatments
June 9, 2023 -
A day in the life of a pharma exec: Lyndra’s Patricia Hurter
May 17, 2023 -
Attracting up-and-coming talent in biotech
May 3, 2023 -
Conditions for worker burnout in biotech are ripe. Here’s how to beat it
April 19, 2023 -
He helped launch the Pfizer COVID vaccine — now this startup CEO is hunting a lingering pandemic foe
April 11, 2023 -
Seamless clinical trials were created to make studies easier — instead, they’ve become more complex
March 29, 2023 -
Viral roots: A look at how modern outbreaks began
March 22, 2023 -
The PharmaVoice 100 — Who makes the cut
March 15, 2023 -
Multimillion-dollar therapies are changing how payers foot the bill
Feb. 28, 2023 -
Managing for resilience: Passage’s ups and downs in gene therapy
Feb. 15, 2023 -
The unique playbook of Biohaven’s CEO
Feb. 8, 2023 -
Gilead’s commercial chief on why 2023 will be a ‘coming out’ year
Jan. 26, 2023 -
After ‘limping along,’ Novavax sees a path forward
Jan. 18, 2023 -
How biotechs can weather the market storm
Jan. 13, 2023